WELLS FARGO & COMPANY/MN

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 72971 SAN FRANCISCO, CA

Back to VRTX Full portfolio

Position in VRTX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$332,670,066

-$3,638,273 QoQ

Shares Held

744,995

+0.4% QoQ

Ownership

0.294%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 98.66509171202492.ToString("F0")% Shared 0.0017449781542158002.ToString("F0")% None 1.3331633098208713.ToString("F0")%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Derivatives in VRTX

reported options exposure · as of Dec 31, 2025

CallValue

$3,082,848

CallShares

6,800

PutValue

$3,082,848

PutShares

6,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,293,431,965 across 386 Biotechnology names. VRTX ranks #1 (25.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	744,995	$332,670,066
2	ALNY	Alnylam Pharmaceuticals, Inc.	342,763	$113,409,991
3	REGN	Regeneron Pharmaceuticals, Inc.	142,021	$109,731,102
4	HALO	Halozyme Therapeutics, Inc.	1,535,737	$99,254,679
5	INSM	INSMED Inc	597,384	$97,684,229
6	ASND	Ascendis Pharma A/S	154,199	$35,269,936
7	EXEL	Exelixis, Inc.	687,304	$29,478,466
8	ARGX	Argenx SE	38,104	$27,825,444

All Filings in VRTX

Export CSV

35 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$332,670,066	744,995	+0.4%	Shares	Defined	2026-05-11
2025-12-31	$336,308,339	741,813	+10809.0%	Shares	Defined	2026-02-13
2025-12-31	$3,082,848	6,800	0.0%	Call	Defined	2026-02-13
2025-12-31	$3,082,848	6,800	-99.1%	Put	Defined	2026-02-13
2025-09-30	$280,933,551	717,326	+2.2%	Shares	Defined	2025-11-13
2025-06-30	$312,553,548	702,052	-0.6%	Shares	Defined	2025-08-14
2025-03-31	$342,364,851	706,169	+2.4%	Shares	Defined	2025-05-13
2024-12-31	$277,722,858	689,652	+19057.0%	Shares	Defined	2025-02-13
2024-12-31	$1,449,720	3,600	-81.1%	Call	Defined	2025-02-13
2024-09-30	$8,836,520	19,000	-97.7%	Put	Defined	2024-11-13
2024-09-30	$386,118,715	830,220	+1.4%	Shares	Defined	2024-11-13
2024-06-30	$383,583,571	818,364	+90829.3%	Shares	Defined	2024-08-13
2024-03-31	$376,209	900	-99.9%	Put	Defined	2024-05-10
2024-03-31	$320,850,680	767,567	+2.5%	Shares	Defined	2024-05-10
2023-12-31	$304,746,774	748,966	+53397.6%	Shares	Defined	2024-02-09
2023-12-31	$569,646	1,400	-99.8%	Put	Defined	2024-02-09
2023-09-30	$271,336,999	780,287	+55634.8%	Shares	Defined	2023-11-13
2023-09-30	$486,836	1,400	0.0%	Put	Defined	2023-11-13
2023-06-30	$492,674	1,400	-99.8%	Put	Defined	2023-08-15
2023-06-30	$284,207,792	807,615	+3.3%	Shares	Defined	2023-08-15
2023-03-31	$246,418,766	782,108	+4.4%	Shares	Defined	2023-05-12
2022-12-31	$216,275,137	748,927	-3.8%	Shares	Defined	2023-02-13
2022-09-30	$225,340,583	778,271	-2.7%	Shares	Defined	2022-11-14
2022-06-30	$225,348,025	799,702	-6.0%	Shares	Defined	2022-08-12
2022-03-31	$222,106,868	851,082	+1065.9%	Shares	Defined	2022-05-16
2022-03-31	$19,050,810	73,000	-91.4%	Call	Defined	2022-05-16
2021-12-31	$185,738,556	845,804	-25.3%	Shares	Defined	2022-02-14
2021-09-30	$205,259,289	1,131,591	-3.6%	Shares	Defined	2021-11-15
2021-06-30	$236,588,606	1,173,380	-4.6%	Shares	Defined	2021-08-16
2021-03-31	$264,327,376	1,230,059	+6928.9%	Shares	Defined	2021-05-13
2021-03-31	$3,760,575	17,500	-98.7%	Call	Defined	2021-05-13
2020-12-31	$308,457,732	1,305,144	-11.5%	Shares	Defined	2021-02-09
2020-09-30	$401,472,238	1,475,350	-3.4%	Shares	Defined	2020-11-05
2020-06-30	$443,317,301	1,527,048	+14.0%	Shares	Defined	2020-08-13
2020-03-31	$318,801,601	1,339,784	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.